Macquarie Group’s Merrimack Pharmaceuticals, Inc. MACK Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change %
Capital Flow Portfolio Weight Portfolio Position
2019
Q1
Sell
-2,034
Closed -$6K 2319
2018
Q4
$6K Buy
+2,034
New +$6K ﹤0.01% 2090
2018
Q2
Sell
-22,662
Closed -$144K 2361
2018
Q1
$144K Sell
22,662
-8,007
-26% -$50.9K ﹤0.01% 1803
2017
Q4
$247K Buy
30,669
+18,683
+156% +$150K ﹤0.01% 1679
2017
Q3
$137K Buy
+11,986
New +$137K ﹤0.01% 1849